Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EllaOne in Charcot-Marie-Tooth disease type 1A
NCT02600286Phase 2Terminated
- Sponsor
- Strasbourg University Hospital
- Start
- Oct 2015
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ulipristal in Charcot-Marie-Tooth disease type 1A (CMT1A), sponsored by Strasbourg University Hospital. Started Oct 2015; status: terminated.
02
Drugs
ulipristal
03
Conditions
Charcot-Marie-Tooth disease type 1A (CMT1A)
Beyond the preview
Go deeper on NCT02600286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02600286.